Home
About
Overview
Sharing Data
ORCID
Help
History (5)
"Women Leading in Neurology", selected participant (1 of 12 participants, out of >80 applicants)
AFM41a: A Novel PAD2 Inhibitor for Sepsis Treatment-Efficacy and Mechanism.
Improving Communication of Actionable Findings in Radiology Imaging Studies and Procedures Using an EMR-Independent System.
Rare Variants in the Functional Domains of Complement Factor H Are Associated With Age-Related Macular Degeneration.
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
"Women Leading in Neurology", selected participant (1 of 12 participants, out of >80 applicants)
2018 -
2019
"Women Leading in Neurology", selected participant (1 of 12 participants, out of >80 applicants)
Awardee:
Susanne Muehlschlegel MD, MPH